According to NKp46 and NKp30 down-modulation, circulating NK cells derived from CRC patients present a lower lytic response against CRC cell lines and reduced cytotoxic capacity and IFN-γ secretion when co-cultured with NK susceptible target cells, such as K562 [81]. The gene discussed is NCR3; the disease is colorectal carcinoma.